Assenagon Asset Management
BNTX icon

Assenagon Asset Management’s BioNTech BNTX Stock Holding History

Assenagon Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.4M Buy
+423,263
New +$39.8M 0.05% 280
2023
Q1 		– Sell
-10,881
Closed -$1.64M – 1416
2022
Q4 		$1.64M Hold
10,881
– – 0.01% 877
2022
Q3 		$1.47M Buy
10,881
+2,052
+23% +$314K 0.01% 804
2022
Q2 		$1.32M Buy
+8,829
New +$1.35M ﹤0.01% 990

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Assenagon Asset Management's BNTX Position: Q2 2026 in Review

Assenagon Asset Management opened a new position in BioNTech (BNTX) in Q2 2026: 423,263 shares worth $39.4M. The stake represents 0.05% of the portfolio and ranks #280 among its holdings. This is a return to the name: Assenagon Asset Management previously reported a position in BNTX as recently as Q4 2022.

Assenagon Asset Management first reported a position in BNTX in Q2 2022 and has held it in 4 quarters since. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Assenagon Asset Management held 423,263 shares of BioNTech worth $39.4M as of Q2 2026.
  • BioNTech was a new Assenagon Asset Management position in Q2 2026.
  • BioNTech made up 0.05% of Assenagon Asset Management's portfolio in Q2 2026, its #280 holding.
  • Assenagon Asset Management first reported a position in BioNTech in Q2 2022 and has held it in 4 quarters since.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.